knowledge -WSS

knowledge

author：leisure time 2025-09-27 23:11:57 - browse：283

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion.

Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price. Intercept expects the deal to close by the end of the year.

The transaction comes three months after the Food and Drug Administration rejected Intercept’s treatment for NASH, an increasingly common fatty liver disease perceived as a potential gold mine by drug companies. Intercept’s medicine, called obeticholic acid, would have been the first approved treatment for NASH, but serious concerns about the risk of drug-related liver damage and uncertainty over whether its modest effects would improve patients’ lives made it unapprovable in the eyes of the FDA.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

WSS

Why some fertility treatments produce more boy babies

Explaining an after

Should insurance cover cosmetic surgery?

Medicare proceeds with plan to claw back hospital funds

Should insurance cover cosmetic surgery?

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Wikipedia

knowledge

knowledge

How to save PrEP access — and even expand it

Why we need mandatory labeling of GMO products

Guidelines to prevent youth baseball injuries need more muscle

All of Us, NIH's precision medicine initiative, gets a big boost

Medicare proposal to cover medical devices draws a mixed reaction

Bill would allow buprenorphine prescription for addiction via telehealth

Hollywood unions extend contract negotiations for actors

Clinicians often fail to acknowledge the pain caused by long Covid

Heart attack and stroke risk calculators need revising

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

focus

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

The Bio Revolution is changing business and society

Achieving telehealth equity for people with hearing loss

Clinicians often fail to acknowledge the pain caused by long Covid

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Louisiana bill approved classifying abortion pills as controlled substances

focus

leisure time

hotspot

focus